Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Randomized Study Evaluating Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in the Treatment of Relapse Ovarian Cancer

NCT01376752 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.

NCT NCT01376752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01376752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Randomized Study Evaluating Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in the Treatment of Relapse Ovarian Cancer
Lead sponsor
UNICANCER
Phase
Phase 3
Overall status
Active, not recruiting
Start date
April 26, 2011
Completion date
May 14, 2027
Enrollment
415 (actual)
Sites
33

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian epithelial cancer recurrent